Showing results (51-60 of 97) with videos related to
Sort By:
Pageof 10
Plos One|July 30, 2011
Cellular immune responses to nine Mycobacterium tuberculosis vaccine candidates following intranasal vaccinationSuraj B Sable, Mani Cheruvu, Subhadra Nandakumar, et al.Vaccines|December 20, 2017
Vaccination with Combination DNA and Virus-Like Particles Enhances Humoral and Cellular Immune Responses upon Boost with Recombinant Modified Vaccinia Virus Ankara Expressing Human Immunodeficiency Virus Envelope ProteinsSailaja Gangadhara, Young-Man Kwon, Subbiah Jeeva, et al.Genes, Brain, and Behavior|August 3, 2020
Transcriptomic approach predicts a major role for transforming growth factor beta type 1 pathway in L-Dopa-induced dyskinesia in parkinsonian ratsShetty Ravi Dyavar, Lisa F Potts, Goichi Beck, et al.Frontiers in Immunology|August 8, 2022
V2 hotspot optimized MVA vaccine expressing stabilized HIV-1 Clade C envelope Gp140 delays acquisition of heterologous Clade C Tier 2 challenges in Mamu-A*01 negative Rhesus MacaquesTiffany M Styles, Sailaja Gangadhara, Pradeep B J Reddy, et al.Virology|June 3, 2006
Studies on GM-CSF DNA as an adjuvant for neutralizing Ab elicited by a DNA/MVA immunodeficiency virus vaccineHarriet L Robinson, David C Montefiori, Francois Villinger, et al.Nature|December 17, 2008
Enhancing SIV-specific immunity in vivo by PD-1 blockadeVijayakumar Velu, Kehmia Titanji, Baogong Zhu, et al.Journal of Virology|July 26, 2019
Human Immunodeficiency Virus C.1086 Envelope gp140 Protein Boosts following DNA/Modified Vaccinia Virus Ankara Vaccination Fail To Enhance Heterologous Anti-V1V2 Antibody Response and Protection against Clade C Simian-Human Immunodeficiency Virus ChallengeTiffany M Styles, Sailaja Gangadhara, Pradeep B J Reddy, et al.Journal of Virology|June 13, 2014
CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus SIV239 vaccine enhances SIV-specific humoral and cellular immunity and improves protection against a heterologous SIVE660 mucosal challengeSuefen Kwa, Lilin Lai, Sailaja Gangadhara, et al.Virology|May 18, 2007
DNA/MVA HIV-1/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challengePragati Nigam, Patricia L Earl, Jeffrey L Americo, et al.Journal of Virology|November 25, 2005
A combination DNA and attenuated simian immunodeficiency virus vaccine strategy provides enhanced protection from simian/human immunodeficiency virus-induced diseaseRama Rao Amara, Kalpana Patel, Genevieve Niedziela, et al.Pageof 10